BioInvent International AB's total assets for Q2 2025 were kr916.67M, an increase of 6.24% from the previous quarter. BOVNF total liabilities were kr105.93M for the fiscal quarter, a 13.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.